US OptionsDetailed Quotes
CUTR241220P4000
- 2.73
- 0.000.00%
15min DelayClose Dec 20 16:00 ET
0.00High0.00Low
2.73Open2.73Pre Close0 Volume0 Open Interest4.00Strike Price0.00Turnover0.00%IV-249.86%PremiumDec 20, 2024Expiry Date3.64Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.10Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Cutera Stock Discussion
Sign in to post a comment
$ABVC BioPharma (ABVC.US)$ - Progress continues in our ADHD program with Phase IIb trials at multiple prominent sites. We aim to have an interim report by Q4 2024. ABV-1601 for MDD in cancer patients has completed Phase I study preparation, including the Site Initiation Visit (SIV). The study is set to initiate by the end of 2024.
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...
25
7
7
turnover is finally starting to turn around, under 20m, float s over 30%, change - up
1
$Cutera (CUTR.US)$
businesswire.co...
businesswire.co...
3
$Cutera (CUTR.US)$
March 21, 2024 04:01 PM Eastern Daylight Time
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today reported financial results for the fourth quarter and full-year ended December 31, 2023.
“We are now squarely focused on our most important priorities, which are operational excellence and building a successful AviClear franchise across the globe.”
Post this
• Consolidated reve...
March 21, 2024 04:01 PM Eastern Daylight Time
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today reported financial results for the fourth quarter and full-year ended December 31, 2023.
“We are now squarely focused on our most important priorities, which are operational excellence and building a successful AviClear franchise across the globe.”
Post this
• Consolidated reve...
2
$Maxeon Solar Technologies (MAXN.US)$
$Faraday Future Intelligent Electric Inc. (FFIE.US)$
$Luminar Technologies (LAZR.US)$
$BigBear.ai Holdings (BBAI.US)$
$Maxeon Solar Technologies (MAXN.US)$
$Beyond Meat (BYND.US)$
$Cassava Sciences (SAVA.US)$
$Lemonade (LMND.US)$
$SunPower (SPWR.US)$
$Advantage Solutions (ADV.US)$
$MicroCloud Hologram (HOLO.US)$
$Cutera (CUTR.US)$
$NextNav (NN.US)$
$Medical Properties Trust Inc (MPW.US)$
$Faraday Future Intelligent Electric Inc. (FFIE.US)$
$Luminar Technologies (LAZR.US)$
$BigBear.ai Holdings (BBAI.US)$
$Maxeon Solar Technologies (MAXN.US)$
$Beyond Meat (BYND.US)$
$Cassava Sciences (SAVA.US)$
$Lemonade (LMND.US)$
$SunPower (SPWR.US)$
$Advantage Solutions (ADV.US)$
$MicroCloud Hologram (HOLO.US)$
$Cutera (CUTR.US)$
$NextNav (NN.US)$
$Medical Properties Trust Inc (MPW.US)$
2
The downgrade in revenue estimates and the increase in loss per share estimates for Cutera, Inc. have led to increased bearishness among analysts. The company's outlook for the next year has been significantly cut, leading to increased caution among shareholders.
1
Investors show pessimism towards Cutera's future due to its low P/S ratio and falling revenue growth. The company's disappointing revenue outlook contributes to its low P/S, which is unlikely to rise unless fortunes change.
1
No comment yet
AddiBee0925 : Hey Jag. Just a heads up. If all goes as planned, the launch for SIDU and SpaceX is on the schedule for this Friday on the 20th. I wouldn't think that it would be rescheduled so soon to the launch, at least no report has said otherwise.
Jaguar8 OP AddiBee0925 : Yes. But there might be a build up of the price before the launch just like LUNR. Hopefully it goes well.
AddiBee0925 Jaguar8 OP : yeah I'm thinking the same
Jaguar8 OP browny_440 : TNXP will be good if FDA releases decision soon
72306783 : I would like to ask, what signals or standards do you use to start building positions? I am still learning... Thank you very much for your Share
View more comments...